VAERS Explorer
Back to explore

Report #2863101

Received Oct 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
65 yrs
State
GA
Recovered
Unknown
Vaccinated
Sep 18, 2025
Onset
Sep 1, 2025
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLUXINFLUENZA (SEASONAL) (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—OT

Symptoms (2)

MalaiseStress

Symptom narrative

Stressed; Feeling sick; Infusion site came out twice this month; Initial information received on 26-Sep-2025 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (non-healthcare professional). This case involves a 65 years old female patient (63 kg) who had stressed, feeling sick and infusion site came out twice this month after receiving Influenza Vaccine and treated with Treprostinil sodium. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Omeprazole, Cetirizine hydrochloride (Zyrtec); Furosemide, Mycophenolate mofetil, Sodium chloride (Saline nasal spray); Paracetamol (Tylenol); Macitentan (Opsumit); Magnesium chelate (Magnesium); Ketamine hydrochloride (Ketamine HCL); Glycine max extract (Lecithin); Apixaban (Eliquis); Fluticasone propionate (Flonase allergy relief); Cod-liver oil (Cod liver oil); Clonidine, Ketoprofen, Ascorbic acid, Biotin, Calcium pantothenate, Cyanocobalamin, Ergocalciferol, Iron, Nicotinamide, Pyridoxine hydrochloride, Retinol, Riboflavin, Thiamine hydrochloride, Tocopheryl acetate (Centrum); Calcium, Oxygen, Montelukast sodium, Lidocaine hydrochloride (Lidocaine HCL); Amitriptyline hydrochloride (Amitriptyline); Gabapentin, Poloxamer and Ondansetron hydrochloride (Ondansetron HCL). On 18-Sep-2025, the patient received an unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (lot number, formulation, expiry date and strength not reported) via unknown route in unknown administration site for Flu vaccination (Influenza immunization). On an unknown date, the patient started taking Treprostinil sodium (0.044 µg/kg, formulation and expiry date unknown) subcutaneous for Pulmonary arterial hypertension. Information on the batch number was requested corresponding to the one at time of event occurrence. On an unknown date in Sep-2025, the patient developed stressed (stress), feeling sick (malaise) and infusion site came out twice this month (device dislocation) (latency approximately few days) following intake of Treprostinil sodium and administration of Influenza Vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for all the events. At time of reporting, the outcome was Unknown for all the events.

Other medications

Omeprazole; Zyrtec; Furosemide; Mycophenolate mofetil; Saline nasal spray; Tylenol; Opsumit; Magnesium; Ketamine HCL; Lecithin; Eliquis; Flonase allergy relief; Cod liver oil; Clonidine; Ketoprofen; Centrum; Calcium; Oxygen; Montelukast sod